BOOK A MEETING
As more innovators join the digital therapeutics (DTx) landscape, understanding the intricacies of running clinical trials in Europe becomes increasingly essential. Navigating the regulatory framework for digital therapeutics in the EU market can be an arduous journey. However, with an understanding of the country-specific regulatory guidelines, rigorous trial design, the journey to commercialization, and lessons from those already in the field, success is achievable. Providers and innovators ready to explore this growing space must be willing to learn and adapt quickly to actualize their market potential.
In this webinar led by the Digital Therapeutics Alliance, we sit down with Perfood and Poppins leadership to talk about the considerations for conducting impactful DTx trials in the European Union (EU) market, specifically focusing on the German DiGA and the French PECAN regulatory bodies.
Tune in to discover how CROs in the DTx space help sponsors navigate these hurdles to successfully conduct clinical trials, delivering essential digital health interventions to patients faster.
Dr. Tim Garnett, Former Chief Medical Officer of Eli Lilly, Joins Lindus Health’s Advisory Board
Welcoming our newest advisor - Dr. Tim Garnett, former CMO at Eli Lilly!
Lindus Health and University of Oxford Publish Study Citing Key Strategies to Foster Diversity in Clinical Trial Participation
This collaboration with University of Oxford explores the perceptions of incentives and barriers to clinical trial participation among both researchers and various underrepresented groups.